* Acadia Healthcare Company Inc ACHC.OQ ACHC.O is
expected
to show a rise in quarterly revenue when it reports results on
May 1 for the period ending March 31 2024
* The Franklin Tennessee-based company is expected to
report a
10.6% increase in revenue to $779.166 million from $704.27
million a year ago, according to the mean estimate from 11
analysts, based on LSEG data.The company's guidance on February
27 2024, for the period ended March 31, was for revenue between
$775.00 million and $785.00 million.
* LSEG's mean analyst estimate for Acadia Healthcare
Company Inc
is for earnings of 81 cents per share. The company's EPS
guidance on February 27 2024, for the period ended March 31, was
between $0.78 and $0.83
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Acadia
Healthcare
Company Inc is $100.00, above its last closing price
of $73.59.
The company's guidance on February 27 2024 for the period ended
March 31 was for Earnings before Interest, Taxes, Depreciation
and Amortization of between USD775 million and USD175 million.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 0.79 0.79 0.85 Beat 7.2
Sep. 30 2023 0.89 0.89 0.91 Beat 2.2
Jun. 30 2023 0.85 0.86 0.92 Beat 7.5
Mar. 31 2023 0.71 0.71 0.75 Beat 5.8
Dec. 0.75 0.75 0.70 Missed -6.6
31 2022
Sep. 30 2022 0.79 0.79 1.64 Beat 108.5
Jun. 30 2022 0.78 0.78 0.84 Beat 8
Mar. 31 2022 0.64 0.64 0.67 Beat 5.4
This summary was machine generated April 29 at 21:14 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)